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SUMMARY
We aimed to explore Campylobacter genotype-speciﬁc risk factors in Australia. Isolates collected
prospectively from cases recruited into a case-control study were genotyped using ﬂaA restriction
fragment-length polymorphism typing (ﬂaA genotyping). Exposure information for cases and
controls was collected by telephone interview. Risk factors were examined for major ﬂaA
genotypes using logistic and multinomial regression. Five ﬂaA genotypes accounted for 325
of 590 (55%) cases – ﬂaA-6b (n=129), ﬂaA-6 (n=70), ﬂaA-10 (n=48), ﬂaA-2 (n=43), ﬂaA-131
(n=35). In Australia, infections due to ﬂaA-10 and ﬂaA-2 were found to be signiﬁcantly
associated with eating non-poultry meat (beef and ham, respectively) in both case-control and
inter-genotype comparisons. All major genotypes apart from ﬂaA-10 were associated with
chicken consumption in the case-control comparisons. Based on several clinical criteria, infections
due to ﬂaA-2 were more severe than those due to other genotypes. Thus genotype analysis may
reveal genotype-speciﬁc niches and diﬀerences in virulence and transmission routes.
INTRODUCTION
The disease burden of Campylobacter infections is
considerable in Australia, where it is the most com-
mon notiﬁable disease [1]. Campylobacter infections
are largely sporadic and estimated to cause about
223 000 cases of gastroenteritis each year [2]. The need
for public health intervention is highlighted by the
steady rise in notiﬁcations in Australia since the early
1990s [1, 3].
Case-control studies of potential risk factors
for campylobacteriosis have been undertaken in
several countries [4–11] including Australia [12, 13].
Consumption of chicken is the most commonly
identiﬁed risk factor for sporadic campylobacteriosis.
However, this and other statistically signiﬁcantly risk
factors often do not explain the majority of cases
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[13, 14]. Other sources of apparently sporadic cam-
pylobacteriosis are diﬃcult to detect using current
case-control study designs.
Further sources of Campylobacter infection may
be detected if strains with distinct ecologies (including
diﬀerential survival characteristics, and therefore
speciﬁc environmental niches or host preference),
with varying virulence (causing disease of variable
severity) anddiﬀerent transmission routes could bedis-
tinguished. Numerous subtyping methods have been
developed and applied to Campylobacter isolates
[15–19]. These methods, used to determine genomic
diversity, generally have been applied to diverse col-
lections of isolates [20, 21]. Methods such as sero-
typing, multilocus sequence typing (MLST) and
pulsed-ﬁeld gel electrophoresis (PFGE) have been
used to distinguish outbreak from sporadic isolates
[18, 22, 23]. In addition, a variety of methods have
been used to compare animal and human isolates.
Some studies have concluded that ﬁnding the same
subtype in animal and human isolates is evidence of
transmission from animals to humans or is evidence
of a common source for animals and humans [17,
24–28]. However, the potential to identify genotype-
speciﬁc risk factors for sporadic infection is yet to be
evaluated.
The aim of this study was to determine sources and
risk factors of Campylobacter jejuni for speciﬁc ﬂaA
genotypes.We hypothesize that the application of ﬂaA
genotyping to isolates from a case-control study may
allow detection of further sources through the exam-
ination of genotype-speciﬁc risk factors. Study isolates
were collected prospectively from sporadic cases re-
cruited into a case-control study and genotyped
using ﬂaA restriction fragment-length polymorphism
(RFLP; ﬂaA genotyping) analysis, a moderate
throughput, low cost method [29] with good corre-
lation with MLST [30]. Genotyping data were linked
to exposure data for the investigation of risk factors.
METHODS
Study base
Data and Campylobacter isolates collected for this
study were drawn from an Australian case-control
study that was conducted in ﬁve states between
September 2001 and September 2002. A description of
the study and risk factors for subjects aged o5 years
was reported by Staﬀord et al. [13]. The study re-
cruited cases and controls from ﬁve of the eight states
and territories in Australia. The largest state, New
South Wales, was excluded because campylobacter-
iosis is not notiﬁable there and the Northern Territory
and Australian Capital Territory were not included in
the study because too few cases are notiﬁed. As pre-
viously described [13], each site aimed to prospectively
recruit 200 cases of all ages using systematic sampling
from a notiﬁable disease register ; every second case
from Tasmania and Victoria, every fourth and sixth
case from Queensland and South Australia, respect-
ively and every case from Western Australia. The
sampling strategy was based on the expected number
of cases notiﬁed from participating laboratories and
the number required to detect signiﬁcant associations
with hypothesized risk factors [13]. Furthermore,
sample size calculations determined that about 550
isolates would probably be collected and that number
would prove suﬃcient to detect signiﬁcant associ-
ations between some genotypes and risk factors.
Cases were deﬁned as individuals with diarrhoea
(o3 or more loose stools in a 24 h period), who had
culture-conﬁrmed C. jejuni infection (and no other
pathogen such as Salmonella, Shigella, or the enteric
protozoa detected), whose isolates were ﬂaA geno-
typed, whose stool samples were collected within
10 days of diarrhoea onset and who were interviewed
within 30 days of onset. Telephone interviews were
conducted when verbal consent was given by the study
subject (or carer if the case was aged<16 years).
Controls were drawn (about one per case) from a
control bank generated during a national cross-
sectional survey of gastroenteritis conducted in 2001;
a description of the survey is given by Hall et al. [31]
and a description of control selection is reported by
Staﬀord et al. [13]. In brief, households were selected
using random digit dialling during the gastroenteritis
survey, a household member was asked to participate
in the survey and subsequently consent to be part of a
control bank. From this control bank, potential con-
trols were selected and frequency-matched to cases by
age bands (0–4, 5–9, 10–19, 20–29, 30–59 and o60
years) in each state at a ratio of 1:1. If a person did
not wish to participate or was excluded on the criteria
(described below), a subsequent person was sought
from the control bank. Once a control had been
selected from a household, that household was no
longer eligible for future selection of controls. Con-
trols were interviewed within 30 days of interview of a
notiﬁed case.
Cases and controls were excluded if they did not
have a phone number, were unable to be contacted
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after at least six attempts, they/their parents were
non-English-speakers, they could not answer ques-
tions, or if a household member had had diarrhoea or
a conﬁrmed Campylobacter infection in the 4 weeks
prior to onset. In addition, cases were excluded if they
were unable to recall the diarrhoea onset date or they
were part of an outbreak.
Questionnaire
A standard questionnaire was administered by tele-
phone to obtain information on a range of variables,
including host factors (underlying illnesses, prior
consumption of antimicrobial agents, antacids and
immune suppressive therapies), overseas travel, din-
ing locations, consumption of water and food (fruit
and vegetables, meat, poultry, seafood, eggs and dairy
products), animal and pet exposures, and demo-
graphics. Cases were asked additional questions
about their illness and treatment. For cases, all ques-
tions related to the 7-day period before their onset of
diarrhoea, except for prior use of antibiotics, antacids
or immune suppressive therapies, which were based
on the preceding 4 weeks. Exposure information was
not collected from subjects who had travelled outside
Australia during the 7-day exposure period. Controls




Isolates from diarrhoeal stool cultures were stored
and subsequently identiﬁed to species level by hippu-
rate hydrolysis and PCR as described previously [32,
33]. Those identiﬁed as C. jejuni using these methods
were ﬂaA genotyped.
ﬂaA genotyping
Flagellin A RFLP typing (ﬂaA genotyping) was
performed according to the method described by
Nachamkin et al. [15]. Brieﬂy, this involved PCR
ampliﬁcation of ﬂaA, followed by digestion of pro-
ducts with the restriction enzyme DdeI and separation
of fragments by agarose gel electrophoresis. Geno-
typing was performed by ﬁve laboratories, using
standardized reagents and methods (including DNA
extraction, PCR, restriction enzyme digestion, agarose
gel electrophoresis and photography), which had been
optimized by one laboratory.
Quality assurance
A set of eight isolates was distributed to the lab-
oratories that genotyped isolates. Tiﬀ images of ﬂaA
genotyping gels were loaded onto a BioNumerics
database located at one laboratory and examined
for comparability. Feedback was provided on accu-
racy of the patterns and image quality. Reaction or
photography conditions were modiﬁed, if necessary,
to produce images consistent with those from prior
testing of the quality assurance set. The positive
control, NCTC 11351, was included in each test
run. GeneRulerTM 100 bp DNA LadderPlus (MBI
Fermentas, Vilnius, Lithuania) was included in lanes
1, 5, 10, and 15 of all gels. If the gel pattern of the
positive control was not compatible with those in-
cluded in the BioNumerics database, gel images were
to be rejected, however, this did not occur.
Assignment of ﬂaA genotypes
Tiﬀ images of gels were loaded onto a BioNumerics
database and patterns were normalized according to
molecular-weight standards on each gel. ﬂaA geno-
types were designated by a number that was assigned
arbitrarily ; numbered genotypes diﬀered from each
other by at least two bands and subtypes of numbered
genotypes, designated by a letter (e.g. ﬂaA-6 and ﬂaA-
6b) diﬀered by a single band only. The numbering of
genotypes was consistent with a previous Australian
study [29, 30] and isolates from the previous study
were included in the BioNumerics library used for
analysis in this study. Genotypes were grouped to-
gether using the Dice band matching coeﬃcient and
UPGMA clustering method with a position tolerance
of 1% and an optimization of 1% which clustered at
>90% similarity [29]. Resultant dendrograms were
checked visually by two researchers and about 10%
were re-veriﬁed by the second researcher in the case of
discrepancies.
Statistical analyses
Logistic regression analysis was used to compare
demographic characteristics and host factors between
study cases and (a) study controls, (b) cases that did
not have isolates ﬂaA genotyped and (c) cases notiﬁed
through the national surveillance system.
Logistic regression analysis was also used to ident-
ify potential risk factors for speciﬁc ﬂaA genotypes.
The exposures reported for cases of each major ﬂaA
genotype were compared to those for all study
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controls combined, in order to increase the power of
hypothesis testing. A ﬁnal model for each genotype
was constructed by including all exposure variables
with P<0.1 (in univariate analyses) and using back-
wards stepwise elimination, controlling for con-
founders (demographic and host factors). Models
were tested for goodness of ﬁt and compared using the
likelihood ratio test. Genotype-speciﬁc population-
attributable fractions (PAF) were calculated for each
risk factor from ﬁnal models for each of the major
ﬂaA genotypes and for the group comprising ‘other’
ﬂaA genotypes.
To allow for the possibility that some food
and environmental exposures were location-speciﬁc,
we included terms for the interaction between
exposure and state (as a categorical variable) in
the logistic regression models. The signiﬁcance of
multiple interaction terms was tested using the likeli-
hood ratio test. Only signiﬁcant interactions are re-
ported.
Multinomial regression was applied to data on
cases to explore diﬀerences in exposure variables for
the major ﬂaA genotypes, using ‘other ’ ﬂaA geno-
types, comprising the remaining study cases, as the
reference group, controlling for confounders. This
type of analysis was also used to compare demo-
graphic and clinical characteristics between cases
infected with each of the major ﬂaA genotypes.
Results are expressed as relative risk ratios (RRRs),
as is appropriate for this case-only analysis [34].
Analyses were performed using Stata version 9.1
(Stata Corporation, College Station, TX, USA).
RESULTS
Recruitment of cases and controls
During the study period there were 8847 Campylo-
bacter notiﬁcations in the ﬁve participating states
and, of these, 1019 cases were recruited and inter-
viewed (12%). There were 590 (58%) cases for
which an isolate was stored, subsequently found to
be C. jejuni, and ﬂaA genotyped, representing 7% of
notiﬁcations. There were no signiﬁcant diﬀerences in
age distribution between 590 study cases and cases
notiﬁed in 2001 but fewer males were included
(52.5% among cases vs. 54.4% for notiﬁcations,
P=0.03). When cases for whom isolates were geno-
typed were compared to cases that did not have
an isolates genotyped for demographic, host factor
and clinical characteristics, a greater number of the
former were educated to school level only [37% vs.
28%; odds ratio (OR) 1.5, 95% conﬁdence interval
(CI) 1.1–2.0] but no further diﬀerences were de-
tected.
A total of 967 controls were recruited and there
were statistically signiﬁcant, but modest, diﬀerences
between study cases and controls with respect to sex,
income, place of residence and use of acid-reducing
medications (Table 1).
ﬂaA genotype distribution
Among 590 isolates, there were 61 diﬀerent ﬂaA geno-
types, of which ﬁve accounted for 325 (55%; an im-
age of the electrophoretic patterns of the major
genotypes is shown in the Fig.), and 21 (4%) were
single isolates. The ﬁve major ﬂaA genotypes com-
prised ﬂaA-6b (n=129, 22%), ﬂaA-6 (n=70, 12%),
ﬂaA-10 (n=48, 8%), ﬂaA-2 (n=43, 7%), ﬂaA-131
(n=35, 6%); the remaining 265 study cases com-
prised the ‘other ’ genotype group used in case-only
analyses. Some geographic diﬀerences were noted for
the major genotypes ; ﬂaA-10, and -131 were identiﬁed
in all states, ﬂaA-6b and -2 were found in four of the
ﬁve states but ﬂaA-6b, the most common genotype,
was not found in South Australia and ﬂaA-6 was
found in South Australia and Queensland only. Of the
major ﬂaA genotypes, only ﬂaA-2, and -10 were de-
tected among the 13 isolates from overseas travellers
(data not shown). The full descriptive epidemiology
of ﬂaA genotypes and detection of clusters will be
reported separately.
The ﬁve major ﬂaA genotypes (ﬂaA-2, -6, -6b,
-10, and -131) were analysed separately for risk fac-
tors.
Patient characteristics and symptom proﬁle
for the major ﬂaA genotypes
Comparison of cases due to each of the ﬁve major
ﬂaA genotypes with those due to all ‘other’ genotypes
using multinomial regression showed no diﬀerences
in the following characteristics (proportions for all
study cases are shown in parentheses) : proportion of
males (53%), those with cramps (89%), persistent
diarrhoea (12%), those that were hospitalized
(13%), those treated with anti-diarrhoeal medications
(48%) or intravenous ﬂuids (12%). A signiﬁcantly
higher proportion of subjects with ﬂaA-2, com-
pared to ‘other’ genotypes, had fever (RRR 2.3,
95% CI 1.1–5.4), bloody diarrhoea (RRR 2.2, 95%
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CI 1.1–4.4) and >20 bowel motions in a 24 h period
(RRR 5.4, 95% CI 1.1–25.7).
Sources of C. jejuni and risk factors
Subjects that had travelled internationally were in-
cluded in the study but exposure information was not
collected. When compared to controls, overseas tra-
vel was signiﬁcantly associated with ﬂaA-10 disease
(OR 14.5, 95% CI 2.3–85.7). A total of 66 exposure
variables were examined in univariate analyses
of cases infected with the major ﬂaA genotypes
who acquired their infections locally, compared to
controls.
Table 1. Comparison of characteristics of study cases with controls
Characteristic
Study cases Controls
OR 95% CINo. % No. %
Male 310/590 52.5 455/967 47.1 1.2 1.0–1.5
Age group (yr)
0–4 80/590 13.6 129/967 13.3 Ref.
5–9 35/590 5.9 69/967 7.1 0.8 0.5–1.3
10–19 56/590 9.5 95/967 9.8 0.9 0.6–1.5
20–29 102/590 17.3 144/967 14.9 1.1 0.8–1.7
30–59 226/590 38.3 384/967 39.7 0.9 0.7–1.3
o60 91/590 15.4 146/967 15.1 1.0 0.7–1.5
Aboriginal/Torres Strait Islander 15/579 2.6 26/958 2.7 1.0 0.5–1.9
English only spoken at home 516/579 89.1 865/959 90.2 0.9 0.6–1.3
Education
Post-secondary school 360/577 62.4 591/950 62.2 1.0 0.8–1.2
Residence
City/urban 36/581 6.2 72/961 7.5 Ref.
Suburban 329/581 56.6 571/961 59.4 1.2 0.8–1.8
Town 134/581 23.1 160/961 16.7 1.7 1.1–2.7
Rural or remote community 45/581 7.8 115/961 12.0 0.8 0.5–1.3
Farm 37/581 6.4 43/961 4.5 1.7 0.9–3.1
Income, AUS$ (2000/2001)
<$25 000 103/495 20.8 204/826 24.7 Ref.
$25 000–50 000 139/495 28.1 263/826 31.8 1.0 0.9–1.4
$51 000–100 000 192/495 38.8 267/826 32.3 1.4 1.1–1.9
>$100 000 61/495 12.3 92/826 11.1 1.3 0.9–2.0
Host factors
Diabetes 28/456 6.1 49/663 7.4 0.8 0.5–1.4
Immunosuppressive condition 169/464 36.4 238/673 35.4 1.0 0.8–1.3
Prior antibiotics 32/582 5.5 58/967 6.0 0.9 0.6–1.4
Acid-reducing medication 99/499 19.8 100/828 12.1 1.8 1.3–2.5
OR, Odds ratio (shown in bold where P<0.05) ; CI, conﬁdence interval ; Ref., reference category.
























Fig. ﬂaA genotype proﬁles of the ﬁve major ﬂaA genotypes.
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Table 2. Final multiple logistic regression models* for exposures associated with major Campylobacter jejuni ﬂaA genotypes
Exposure$
OR and 95% CI for exposures among those infected with C. jejuni ﬂaA genotypes
[Population-attributable fraction, 95% CI]#
ﬂaA-2· ﬂaA-6 ﬂaA-6bk ﬂaA-10" ﬂaA-131# Other**
(n=43) (n=70) (n=129) (n=48) (n=35) (n=265)
Chicken 3.6 (1.3–10.3)
[65.5%, 11.6–86.5]
Undercooked 4.7 (1.7–13.4) 3.6 (1.1–12.9) 3.6 (1.9–6.6)
chicken [17.0%, 2.2–30.9] [9.8%, n.c.] [7.7%, 3.3–11.7]
Barbecued chicken 1.9 (1.2–2.9)
[16.8%, 3.5–28.3]
Undercooked beef 2.6 (1.2–5.5)
[17.2%, 0.5–31.2]
Diced beef 0.6 (0.3–0.8)
Any sausage 0.3 (0.1–0.7)
Veal 0.3 (0.1–0.9)
Oﬀal 2.9 (1.1–7.9) 11.4 (4.1–31.8) 2.5 (1.1–6.0)
[4.5%, n.c.] [15.9%, 5.5–25.2] [2.7%, n.c.]
Pate´ 2.2 (1.1–4.6) 3.3 (1.2–9.6)
[3.8%, n.c.] [7.8%, n.c.]
Ham 2.4 (1.1–5.2)
[39.3%, 1.0–62.8]
Organic fruit/vegetables 0.4 (0.2–0.9) 0.5 (0.3–0.9)




Pet chicken 2.1 (1.1–4.3)
[5.3%, n.c.]
Pet chicken 20.6 (3.0–117.4) 10.2 (2.6–40.4)
<6 months [8.2%, 0.4–15.4] [13.4%, 0.8–24.4]
Farm birds 11.3 (2.5–51.9)
[5.8%, n.c.]
Poor barbeque 4.4 (1.2–16.3) 4.6 (1.2–18.4) 4.4 (1.1–17.5)
technique [8.7%, n.c.] [7.6%, n.c.] [6.9%, n.c.]
OR, Odds ratio, CI, conﬁdence interval, n.c., 95% CI unable to be calculated due to small numbers.
* Logistic regression models controlled for age, sex (and state, when appropriate).
# Population-attributable fraction shown in bold within square brackets with 95% CI, determined for cases infected with each ﬂaA genotype ; blank cells indicate that no
statistically signiﬁcant association was found for the respective ﬂaA genotype and exposure.
$ Exposure period of 7 days.
· Model for this ﬂaA genotype included state.
k Model for this ﬂaA genotype included consumption of acid-reducing medications.
" Model for this ﬂaA genotype included chronic gastrointestinal illness and immunosuppressive therapies.
# Model for this ﬂaA genotype included age and place of residence.






























In ﬁnal multivariate models, constructed to explain
exposures associated with locally acquired disease
(Table 2), infection with ﬂaA-6b, the most common
ﬂaA genotype, was independently associated with
consumption of barbecued chicken, oﬀal, pate´ and
exposure to pet chickens. The second most common
ﬂaA genotype, ﬂaA-6, was independently associated
with consuming chicken and exposure to farm birds
(ducks, geese, etc.). Infection with ﬂaA-10 was as-
sociated with undercooked beef, oﬀal, pate´, exposure
to young pet chickens (aged <6 months), and poor
food handling. ﬂaA-131 was associated with chicken
(meat and pets) and poor food handling, and ﬂaA-2
was associated with consumption of undercooked
chicken, ham, exposure to puppies and poor food-
handling practices (Table 2). When all ‘other ’ ﬂaA
genotypes combined (comprising 56 ﬂaA genotypes)
were compared to controls, disease among this group
was associated with undercooked chicken, oﬀal, and
bottled water (Table 2). Of the seven ﬂaA-10 case-
patients that consumed oﬀal, three speciﬁed lamb,
one chicken and the remaining three cases did not
indicate a species. Of the seven ﬂaA-6b case-patients
that consumed oﬀal, two speciﬁed lamb, the remain-
ing gave no details on species. Among ﬂaA-6b and -10
cases that ate oﬀal, there was no geographic or time
clustering. While the odds ratios for some of the risk
factors implicated may be of borderline statistical
signiﬁcance, some (e.g. oﬀal and contact with pet
chickens and farm birds) were unusually high. In the
ﬁnal multivariate models for each of the major ﬂaA
genotypes, 74% of ﬂaA-2 cases, 71% of ﬂaA-6 cases,
30% of ﬂaA-6b cases, 57% of ﬂaA-10 cases, 30% of
ﬂaA-131 cases, and 16% of ‘other’ ﬂaA genotypes
were attributed to signiﬁcant exposures (Table 2).
For the case-only comparisons, we used multi-
nomial regression analyses to determine distinct ex-
posures among the major ﬂaA genotypes, as shown
in Table 3. ﬂaA-2, ﬂaA-6b and ﬂaA-10 diﬀered from
the comparison group in their exposure to various
types of non-poultry meats. Signiﬁcant exposures as-
sociated with ﬂaA-10 were diﬀerent from those as-
sociated with ﬂaA-6b and ﬂaA-131, and reﬂected
exposures associated with disease due to those ﬂaA
genotypes in the ﬁnal models (Table 2). ﬂaA-2 in-
fected cases were signiﬁcantly more likely to consume
ham (Tables 2 and 3). Poultry meat exposures did not
diﬀer between ﬂaA types in multinomial regression
analyses (Table 3), but were signiﬁcantly associated
with disease due to ﬂaA-2, -6, -6b and -131 genotypes
when compared to healthy controls (Table 2).
DISCUSSION
Case-control studies of campylobacteriosis have con-
sistently identiﬁed chicken consumption as the most
commonly associated risk factor [7, 9, 11, 13, 35].
Similarly we found chicken associated with disease
due to four out of ﬁve major ﬂaA genotypes, sug-
gesting that chicken harbour a range of C. jejuni geno-
types. Interventions aimed at minimizing chicken
contamination are needed to reduce the burden of
disease, and have been initiated in Iceland and Den-
mark [36, 37]. Here we have attempted to determine
whether separate analysis of C. jejuni genotypes for
risk factors may provide insights into further sources
of this important disease.
We demonstrated the beneﬁt of using molecular
methods to more speciﬁcally deﬁne cases of campy-
lobacteriosis to study possible risk factors for infec-
tion. We found that illness due to C. jejuni genotype
ﬂaA-10 was independently associated with under-
cooked beef consumption. In both case-control and
case-only comparisons undercooked beef was associ-
ated with ﬂaA-10 disease (Tables 2 and 3). Non-
poultry meat has not previously been identiﬁed as a
risk factor for campylobacteriosis in Australia [13]
(L. E. Unicomb et al., unpublished results). Consump-
tion of raw milk and/or contact with calves have
been implicated in four Australian outbreaks [38]
(OzFoodNet Outbreak Register, M. Kirk, personal
communication, July 2006) and exposure to non-
poultrymeats and bovine husbandry have been associ-
ated with Campylobacter illness in case-control
studies conducted in other countries [5, 8, 9, 11]. By
way of comparison, the case-control study from
which subjects in this study were drawn had 881 cases
and 833 controls aged >5 years. It found under-
cooked chicken, oﬀal, ownership of domestic chick-
ens aged <6 months, and domestic dogs aged <6
months as risk factors [13].
Disease caused by ﬂaA-2 was associated with ex-
posure to ham in both case-control and case-only
comparisons (Tables 2 and 3). This ﬁnding was
unexpected, since pigs are predominantly (but not
exclusively) infected with C. coli [39]. Previously, a
ham-containing salad has been implicated in a C. coli
outbreak [40] and it has been detected as a risk factor
in a case-control study conducted in the United
States [9]. It is unclear how processed meats such as
ham could be the source of disease; contamination at
retail outlets from raw meats may occur. Alterna-
tively, this ﬁnding may reﬂect cross-contamination
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Chicken 90% 1.5 (0.5–4.5) 93% 2.4 (0.8–7.2) 82% 0.8 (0.4–1.4) 85% 1.0 (0.4–2.5) 85% 0.9 (0.3–2.8) 85%
Undercooked 12% 1.0 (0.4–2.8) 6% 0.5 (0.2–1.5) 6% 0.5 (0.2–1.2) 5% 0.4 (0.1–1.5) 9% 0.8 (0.2–2.9) 12%
Barbecued 38% 0.6 (0.3–1.3) 37% 0.6 (0.3–1.0) 47% 0.9 (0.6–1.4) 46% 1.0 (0.5–1.9) 51% 0.9 (0.4–1.8) 49%
Non-poultry meat
Undercooked beef 17% 1.1 (0.5–2.7) 14% 0.9 (0.4–2.1) 30% 1.1 (0.6–2.0) 21% 2.5 (1.2–5.2) 16% 1.7 (0.7–4.3) 15%
Diced beef 21% 1.7 (0.7–4.2) 7% 0.5 (0.2–1.5) 22% 1.8 (1.0–3.4) 11% 0.8 (0.3–2.5) 26% 2.2 (0.8–5.7) 13%
Any sausage 34% 1.0 (0.5–2.0) 14% 0.3 (0.1–0.6) 35% 1.0 (0.6–1.6) 13% 0.3 (0.1–0.7) 45% 1.4 (0.5–3.0) 35%
Veal 5% 0.7 (0.2–3.3) 12% 1.8 (0.7–4.5) 4% 0.5 (0.2–1.5) 11% 1.7 (0.5–5.3) 4% 0.5 (0.1–3.8) 7%
Oﬀal 0% — 3% 0.6 (0.1–2.9) 5% 1.2 (0.5–3.2) 16% 3.9 (1.4–10.8) 0% — 5%
Pate´ 5% 1.1 (0.2–5.3) 6% 1.4 (0.4–4.6) 9% 2.3 (1.1–5.5) 13% 3.4 (1.2–9.8) 0% — 4%




10% 1.6 (0.5–5.0) 7% 1.1 (0.4–3.3) 6% 0.8 (0.3–2.1) 10% 1.5 (0.5–4.7) 6% 0.9 (0.2–4.2) 7%
Environmental
Bottled water 12% 1.2 (0.4–3.3) 11% 1.1 (0.5–2.6) 6% 0.6 (0.2–1.3) 16% 1.5 (0.6–3.7) 9% 0.9 (0.3–3.2) 6%
Puppy 8% 0.9 (0.2–2.4) 5% 0.5 (0.2–1.9) 4% 0.4 (0.2–1.2) 7% 0.7 (0.2–2.7) 3% 0.3 (0.0–2.3) 8%
Pet chicken 7% 0.7 (0.2–2.4) 7% 0.7 (0.2–1.8) 11% 1.1 (0.6–2.2) 9% 0.9 (0.3–2.7) 20% 1.9 (0.8–4.9) 10%
Pet chicken
<6 months
0% — 4% 0.5 (0.3–7.3) 2% 0.7 (0.2–2.8) 4% 1.5 (0.3–7.3) 11% 3.1 (0.8–11.2) 3%
Farm birds 2% 1.6 (0.2–14.8) 4% 2.9 (0.6–13.2) 1% 0.5 (0.1–4.6) 2% 1.5 (0.2–13.4) 0% — 2%
Poor barbeque
technique
9% 2.0 (0.6–6.5) 1% 0.3 (0.0–2.2) 3% 0.6 (0.2–2.0) 6% 1.3 (0.4–4.8) 9% 2.2 (0.6–8.5) 5%
* Multinomial models controlled for age and sex.
# All cases with ﬂaA genotypes apart from the ﬁve major ﬂaA genotypes.
$ Relative risk ratio (RRR) with 95% conﬁdence intervals (CI) given in parentheses. RRR and 95% CIs given in bold indicate that a statistically signiﬁcant diﬀerence was






























of ham and other foods during preparation in the
home.
Consumption of oﬀal (from a variety of species)
was associated with disease due to ﬂaA-6b, -10
and ‘other’ genotypes, and was also reported for
all Campylobacter species and genotypes in an
Australian case-control study [13]. Furthermore,
duck liver consumption has been implicated in one
Australian outbreak (OzFoodNet Outbreak Register,
M. Kirk, personal communication, July 2007).
Gel patterns for ﬂaA-6 and ﬂaA-6b genotypes dif-
fered by the size of one band (Fig.), probably from an
insertion or deletion in the ﬂaA gene. ﬂaA-6 was de-
tected in a previous study from January 1999 to July
2001 in New South Wales [29, 30] and has been de-
tected in a subsequent study in South Australia from
November 2005 to March 2006 (B. Coombs, personal
communication, December 2006). Geographic and
temporal diﬀerences in ﬂaA-6 and -6b distribution
suggest that one may be a variant of the other. When
ﬂaA-6 and -6b were analysed as a single genotype
(controlling for the potential confounders age and
sex) similar variables were signiﬁcantly associated
with disease, in univariate models, as those for the
more common ﬂaA-6b alone (data not shown). The
two genotypes were analysed separately as we could
not assume that they are variants without further
laboratory investigations.
Clinical manifestations diﬀered slightly among
those infected with the major ﬂaA genotypes with
ﬂaA-2 infections apparently more severe than those
due to other genotypes ; this suggests that there may
be diﬀerences in virulence between ﬂaA genotypes.
While the diﬀerences between ﬂaA-2 study cases and
others were small, they were consistent for symptoms
that resulted in missing school, work, recreation or
other activities. We have previously reported that ﬂaA
genotypes closely predicted MLST; 88% of ﬂaA-2
isolates, when tested by MLST, belonged to clonal
complex (CC) 48 [30]. AmongCC48human isolates on
the international MLST database (http://pubmlst.
org/campylobacter ; accessed 11 July, 2007), those
included had caused Guillain–Barre´ syndrome,
Miller–Fisher syndrome and systemic disease in ad-
dition to gastroenteritis. Genotype-speciﬁc diﬀerences
in symptoms by age could not be explored in this
study as numbers in each age group were small.
Our ﬁndings should be considered in the light of
study limitations. Selection bias in recruitment of
controls is possible, since people who spend more time
at home would be more easily contactable, but several
factors were controlled for in analyses. Measurement
biases may have occurred as we relied on information
from participants that was not validated. However,
this applied to both cases and controls. Interviewer
bias may have occurred as interviewers knew which
interviewees were cases and controls ; and recall bias
was possible since cases potentially would have better
recall than controls. Study cases were selected from
notiﬁed cases, which include those with more severe
disease. Study cases for whom isolates were not geno-
typed, had similar characteristics to those that were
genotyped, a greater number of the former were edu-
cated to school level only; this small diﬀerence may
have had an impact on exposures. We conducted
many hypothesis tests, so it is plausible that some
statistically signiﬁcant diﬀerences may have arisen by
chance; of the 66 exposure variables examined for
each subtype, an average of three are expected due to
chance alone (using the 5% level of signiﬁcance). Our
ﬁndings therefore need to be replicated by further
studies to conﬁrm our results.
Detecting genotype-speciﬁc risk factors may be
better determined by enrolling cases based on their
isolate subtype results, focusing on the more common
subtypes, thereby including suﬃcient sample size to
test hypotheses. This would further be enhanced by
studies of the distribution of ﬂaA genotypes of non-
human C. jejuni isolates ; such data on Australian
non-human isolates are not available. Information on
genotypes for other countries is available from the
international MLST database. As stated above, ﬂaA
genotypes can closely predict MLST CCs: 96% of
Australian ﬂaA-6 isolates belong to CC 257, 91% of
ﬂaA-10 to CC 354 and 88% of ﬂaA-2 to CC 48 [30].
Among the data from various countries on the MLST
database, these clonal complexes have been detected
in a variety of non-human samples and countries : CC
257 (ﬂaA-6) was detected from bovine, avian (poultry
and other avian), ovine and porcine samples, CC 354
(ﬂaA-10) from bovine, poultry (including environ-
mental) and ovine samples and CC 48 (ﬂaA-2) from
bovine, avian (poultry, poultry environment and
other avian), ovine, water, sand and domestic pet
samples. While these data could potentially be useful
in supporting ﬁndings from the case-control and case-
case analyses, only one of the 124 non-human isolates
from the CC 257, 354 and 48 isolates on the data-
base was from Australia. Determining ﬂaA genotypes
from systematically collected, non-human sources in
Australia may be useful to identify potential re-
servoirs of genotypes.
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ﬂaA genotyping is a gel-based method which has
limitations; it requires standardization to achieve
comparable results across laboratories but is rapid
and cheap. Ideally, this method would be automated
to achieve ‘high throughput ’ status. There are reports
of instability in the ﬂaA locus [41] but the majority of
C. jejuni isolates are apparently genetically stable in
this region over time [26, 42, 43] and that instability
may be strain speciﬁc. Sequence-based methods such
as MLST remove dependence on visual and poten-
tially subjective, genotype assignment but require
expensive equipment to handle medium to high
numbers of isolates and reagents are costly [29, 44].
Isolates from this study were genotyped retro-
spectively, but ‘real time’, genotyping of notiﬁed case
isolates would be preferable, to enable rapid detection
of temporal clusters using a library of common ﬂaA
genotypes and should be feasible.
This is the ﬁrst study to suggest the value of ﬂaA
genotyping for identifying strain-speciﬁc risk factors
for Campylobacter. Case-control analyses using
logistic regression and case-only analyses using multi-
nomial regression were employed to detect risk factors
for C. jejuni ﬂaA genotypes among a selection of
notiﬁed cases drawn from ﬁve Australian states over a
12-month period. Diﬀerences were detected for symp-
tom proﬁle, geographic distribution and exposures
between ﬂaA genotypes. The value of ﬂaA genotyping
is therefore worthy of further investigations in studies
with a larger sample size and in other settings, and
particularly in the course of outbreak investigations.
The ability of ﬂaA genotyping to detect clusters and
outbreaks among apparently sporadic notiﬁed cases
will be assessed in a separate report (L. E. Unicomb
et al., unpublished observations).
APPENDIX. Australian Campylobacter Subtyping
Study Group (listed in alphabetical order) :
Penny Adamson (Flinders Medical Centre, South
Australia), Rosie Ashbolt (Public and Environmental
Health Service, Department of Health and Human
Services, Hobart), Kellie Cheung (Institute of Clinical
Pathology and Medical Research, Westmead, New
South Wales), Barry Combs (Department of Human
Services, Adelaide, South Australia), Craig Dalton
(Hunter New England Population Health, Newcastle,
New South Wales), Steve Djordjevic (Elizabeth
Macarthur Agricultural Institute, Camden, New
South Wales), Robyn Doyle (Institute of Medical
and Veterinary Science, Adelaide, South Australia),
John Ferguson (Hunter New England Health
Service, Newcastle, New South Wales), Lyn Gilbert
(Institute of Clinical Pathology and Medical
Research, Westmead, New South Wales), Rod
Givney (Department of Human Services, Adelaide,
South Australia), David Gordon (Flinders Medical
Centre, Bedford Park, South Australia), Joy Gregory
(Department of Human Services, Melbourne,
Victoria), Geoﬀ Hogg (Microbiological Diagnostic
Unit, University of Melbourne, Parkville, Victoria),
Tim Inglis (Division of Microbiology & Infectious
Diseases, PathWest, Nedlands, Western Australia),
Peter Jelfs (Institute of Clinical Pathology and
Medical Research, Westmead, New South Wales),
Martyn Kirk (Department of Health and Age-
ing, Canberra, Australian Capital Territory), Karin
Lalor (Department of Human Services, Melbourne,
Victoria), Jan Lanser (Institute of Clinical Pathology
andMedical Research,Westmead,New SouthWales),
Lance Mickan (Institute of Medical and Veterinary
Science, Adelaide, South Australia), Lyn O’Reilly
(Division of Microbiology & Infectious Diseases,
PathWest, Nedlands, Western Australia), Rosa Rios
(MicrobiologicalDiagnosticUnit, Parkville,Victoria),
Minda Sarna (Department of Health, Perth, Western
Australia), Hemant Sharma (Hunter New England
Health Service, Newcastle New South Wales), Helen
Smith (Queensland Health Scientiﬁc Services, Co-
opers Plains, Queensland), Leanne Unicomb (Hunter
New England Population Health and National
Centre for Epidemiology and Population Health,
Australian National University, Canberra, ACT),
Mary Valcanis (Microbiological Diagnostic Unit,
University of Melbourne, Parkville, Victoria).
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